In addition, given that DRAK1 expression is significantly associated with paclitaxel resistance in cervical cancer cells and tumorigenesis of paclitaxel-resistant cells, DRAK1 may serve as a potential predictive value for overcoming the therapeutic resistance of cervical cancers. The gene discussed is STK17A; the disease is cervical cancer.